Cutaneous Mucormycosis of the Interscapular Region in an Immunocompetent Patient

Pankil Doshi, Yash Sanghvi, J. Doctor, Vaibhavi Parsaniya
{"title":"Cutaneous Mucormycosis of the Interscapular Region in an Immunocompetent Patient","authors":"Pankil Doshi, Yash Sanghvi, J. Doctor, Vaibhavi Parsaniya","doi":"10.33590/emjmicrobiolinfectdis/20-00243","DOIUrl":null,"url":null,"abstract":"Mucormycosis is an invasive fungal infection caused by opportunistic fungi of the phylum Glomeromycotan, subphylum Mucormycotina, mainly affecting individuals with immunosuppression. Cutaneous mucormycosis is the third most common clinical form of the disease preceded by pulmonary and rhinocerebral mucormycosis. The usual factors predisposing to this infection are individuals who are immunocompromised with conditions like HIV, haematological malignancies, and diabetes mellitus, but a significant proportion of patients are immunocompetent. The agents of mucormycosis are abundantly present in nature and are transmitted to the skin by direct inoculation. It may be due to needle sticks, stings, and bites by animals, motor-vehicle accidents, natural disasters, and burn injuries. The clinical presentation is non-specific, but an indurated plaque that rapidly evolves to necrosis (eschar) is a common finding. The infection can invade locally, and also penetrate into the adjacent fat, muscle, fascia, and bone, or become disseminated. It is difficult to diagnose because of the non-specific presentation of mucormycosis. Biopsy and culture should be performed. Treatment consists of multidisciplinary management, including surgical debridement, use of antifungal drugs (amphotericin B and posaconazole), and reversal of underlying risk factors, when possible. Mortality rates are significant, ranging from 4% to 10% in localised mucormycosis infection, but are lower than the other forms of the disease. The authors present a case here of a 38-year-old immunocompetent male with cutaneous mucormycosis at the interscapular region.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ. Microbiology & infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjmicrobiolinfectdis/20-00243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Mucormycosis is an invasive fungal infection caused by opportunistic fungi of the phylum Glomeromycotan, subphylum Mucormycotina, mainly affecting individuals with immunosuppression. Cutaneous mucormycosis is the third most common clinical form of the disease preceded by pulmonary and rhinocerebral mucormycosis. The usual factors predisposing to this infection are individuals who are immunocompromised with conditions like HIV, haematological malignancies, and diabetes mellitus, but a significant proportion of patients are immunocompetent. The agents of mucormycosis are abundantly present in nature and are transmitted to the skin by direct inoculation. It may be due to needle sticks, stings, and bites by animals, motor-vehicle accidents, natural disasters, and burn injuries. The clinical presentation is non-specific, but an indurated plaque that rapidly evolves to necrosis (eschar) is a common finding. The infection can invade locally, and also penetrate into the adjacent fat, muscle, fascia, and bone, or become disseminated. It is difficult to diagnose because of the non-specific presentation of mucormycosis. Biopsy and culture should be performed. Treatment consists of multidisciplinary management, including surgical debridement, use of antifungal drugs (amphotericin B and posaconazole), and reversal of underlying risk factors, when possible. Mortality rates are significant, ranging from 4% to 10% in localised mucormycosis infection, but are lower than the other forms of the disease. The authors present a case here of a 38-year-old immunocompetent male with cutaneous mucormycosis at the interscapular region.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
免疫正常患者肩胛间区皮肤毛霉病
毛霉菌病是一种侵袭性真菌感染,由毛霉菌门毛霉菌亚门的机会性真菌引起,主要影响免疫抑制个体。皮肤毛霉菌病是该疾病的第三种最常见的临床形式,仅次于肺和鼻脑毛霉菌病。导致这种感染的常见因素是患有HIV、血液系统恶性肿瘤和糖尿病等免疫功能低下的患者,但有很大一部分患者具有免疫功能。毛霉菌病的病原体在自然界中大量存在,并通过直接接种传播到皮肤。这可能是由于针刺、动物蜇伤、机动车事故、自然灾害和烧伤。临床表现是非特异性的,但硬结斑块迅速发展为坏死(焦痂)是一种常见的发现。感染可以局部侵袭,也可以渗透到邻近的脂肪、肌肉、筋膜和骨骼,或变得播散。由于毛霉菌病的非特异性表现,很难诊断。应进行活检和培养。治疗包括多学科管理,包括手术清创,使用抗真菌药物(两性霉素B和泊沙康唑),并在可能的情况下逆转潜在的风险因素。局部毛霉菌病感染的死亡率很高,从4%到10%不等,但低于其他形式的疾病。作者报告了一例38岁的免疫功能正常男性,其肩胛间皮肤毛霉菌病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ECCMID 2023 Abstract Highlights Clostridioides difficile Infection: Targeting an Unwelcome and Persistent Threat SARS-CoV-2 Pandemic and Neisseria meningitidis Serogroup B Invasive Infections: Insights From Italian Surveillance Data and Vaccination Rates Providing Expert Consultation in a World Living with COVID-19 Interview: Anne L. Wyllie
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1